September 2018 Issue

GO TO FULL ISSUE

Med Updates

Epidiolex
cannabidiol oral soluation
An anti-epileptic for treating childhood-onset Lennox-Gestaut and Dravet syndrome.

Lucemyra
lofexidine
An alpha-2 agonist to reduce opioid withdrawal symptoms.

Andexxa
inactivated recombinant factor Xa
Reversal agent for the factor Xa inhibitors apixaban and rivaroxaban.

OTHER MED UPDATES